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Abstract
Background: The endothelial-blood/tissue barrier is critical for maintaining tissue homeostasis. The ear harbors a unique
endothelial-blood/tissue barrier which we term ‘‘blood-labyrinth-barrier’’. This barrier is critical for maintaining inner ear
homeostasis. Disruption of the blood-labyrinth-barrier is closely associated with a number of hearing disorders. Many
proteins of the blood-brain-barrier and blood-retinal-barrier have been identified, leading to significant advances in
understanding their tissue specific functions. In contrast, capillaries in the ear are small in volume and anatomically complex.
This presents a challenge for protein analysis studies, which has resulted in limited knowledge of the molecular and
functional components of the blood-labyrinth-barrier. In this study, we developed a novel method for isolation of the stria
vascularis capillary from CBA/CaJ mouse cochlea and provided the first database of protein components in the blood-
labyrinth barrier as well as evidence that the interaction of Na
+/K
+-ATPase a1 (ATP1A1) with protein kinase C eta (PKCg) and
occludin is one of the mechanisms of loud sound-induced vascular permeability increase.
Methodology/Principal Findings: Using a mass-spectrometry, shotgun-proteomics approach combined with a novel
‘‘sandwich-dissociation’’ method, more than 600 proteins from isolated stria vascularis capillaries were identified from adult
CBA/CaJ mouse cochlea. The ion transporter ATP1A1 was the most abundant protein in the blood-labyrinth barrier.
Pharmacological inhibition of ATP1A1 activity resulted in hyperphosphorylation of tight junction proteins such as occludin
which increased the blood-labyrinth-barrier permeability. PKCg directly interacted with ATP1A1 and was an essential
mediator of ATP1A1-initiated occludin phosphorylation. Moreover, this identified signaling pathway was involved in the
breakdown of the blood-labyrinth-barrier resulting from loud sound trauma.
Conclusions/Significance: The results presented here provide a novel method for capillary isolation from the inner ear and
the first database on protein components in the blood-labyrinth-barrier. Additionally, we found that ATP1A1 interaction
with PKCg and occludin was involved in the integrity of the blood-labyrinth-barrier.
Citation: Yang Y, Dai M, Wilson TM, Omelchenko I, Klimek JE, et al. (2011) Na
+/K
+-ATPase a1 Identified as an Abundant Protein in the Blood-Labyrinth Barrier That
Plays an Essential Role in the Barrier Integrity. PLoS ONE 6(1): e16547. doi:10.1371/journal.pone.0016547
Editor: Aernout Luttun, Katholieke Universiteit Leuven, Belgium
Received August 30, 2010; Accepted December 21, 2010; Published January 31, 2011
Copyright:  2011 Yang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Institutes of Health grants R03-DC008888 (X.S.), R01-NIDCD DC010844 (X.S.), R01-DC000105 (A.L.N.), P30-
DC005983, and Oregon Opportunity funds to the Oregon Health & Science University Proteomics Shared Resource. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: shix@ohsu.edu
Introduction
The cochlear blood-labyrinth-barrier, located in the stria
vascularis, is essential for cochlear solute homeostasis and prevents
the influx of toxic substances into the inner ear [1,2]. Disruption of
the blood-labyrinth barrier is closely associated with the pathogen-
esis of a number of hearing disorders, such as autoimmune inner ear
disease, Meniere’s disease, meningitis-associated labyrinthitis and
genetic diseases [3,4,5,6]. Furthermore, loss of blood-labyrinth
barrier integrity occurs early and prominently during noise-induced
hearingloss[7].Developmentofnewtreatmentsforblood-labyrinth
barrier disruption-related hearing loss requires a better understand-
ing of the molecular structure of the blood-labyrinth barrier, as well
as the molecular mechanisms that control the barrier integrity.
Many proteins of the blood-brain barrier and blood-retinal
barrier have been identified, leading to significant advances in our
understanding of their tissue specific functions [8,9]. In contrast,
stria vascularis capillaries are small in volume and anatomically
complex. This presents a challenge for protein analysis studies,
which has resulted in limited knowledge of the molecular and
functional components of the blood-labyrinth barrier. However,
recent technical advances have allowed for proteomic identifica-
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e16547tion and quantification of blood barrier proteins by advanced
analytical mass spectrometry. In this paper, we describe a novel
‘‘sandwich-dissociation’’ method for isolation of stria vascularis
capillaries. Using a mass spectrometry-based, shotgun-proteomics
approach [10], more than 600 proteins were identified from
isolated mouse stria vascularis capillaries. Strikingly, a high
number of identified proteins were predicted to be involved in
the metabolic and transport processes required to meet the high
metabolic requirements of audition. For example, the most
abundant protein identified in the blood-labyrinth barrier was
the ion transporter Na
+/K
+-ATPase a1 subunit (ATP1A1). In
addition, stria vascularis capillaries were found to be enriched for
tight junction (TJ) and cell adhesion proteins that are indicative of
the blood-labyrinth barrier’s impermeable nature.
Na
+/K
+-ATPase, a heterodimer of catalytic a and b subunits, is
a membrane bound enzyme primarily involved in generation of
Na
+ and K
+ gradients across plasma membranes and in
determination of cytoplasmic Na
+ levels [11,12]. The Na
+ pump
generates this ionic gradient through ATP dependent pumping of
three Na
+ ions out of the cell and two K
+ ions in. The Na
+ pump is
essential for the maintenance of physiological functions of many
cell types by regulating cell volume, intracellular ion balance and
tight junction protein [13,14]. Furthermore, in this study, we
found interactions between the transporter, ATP1A1, a protein
kinase, PKCg, and a TJ protein, occludin, in the blood-labyrinth
barrier, decreased Na
+/K
+-ATPase activity results in occludin
hyperphosphorylation by PKCg and loosening of TJ contact
points causing increased permeability in noise-induced blood-
labyrinth barrier disruption.
Materials and Methods
Animals
The 130 CBA/CaJ mice used in this study (6 weeks old, both
male and female, Cat# 000654) were purchased from Jackson
laboratory (Bar Harbor, Maine, USA). All procedures were
reviewed and approved by the Institutional Animal Care and
Use Committee at Oregon Health & Science University (IACUC
approval number: B11265).
Cochlear stria vascularis capillary isolation
Cochlear stria vascularis capillaries were isolated from 6-week-
old CBA/CaJ mice. The capillary isolation was achieved with a
special procedure we developed and named the ‘‘sandwich-
dissociation’’ method. Specifically, after cardiovascular perfusion
with saline, the auditory bulla was dissected, rapidly removed, and
placed in a petri dish filled with a physiological solution containing
125 mmol/L NaCl, 3.5 mmol/L KCl, 1.3 mmol/L CaCl2,
1.5 mmol/L MgCl2, 0.51 mmol/L NaH2PO4, 10 mmol/L
HEPES, and 5 mmol/L glucose at pH 7.4 with osmolarity
adjusted to 310 mmol/kg. Each turn of the bony cochlear lateral
wall containing the spiral ligament and stria vascularis was
separated from the organ of Corti, and the stria vascularis was
gently peeled away from the spiral ligament with Dumont
Tweezers (110 mm, 0.160.06 mm tip) and a Tungsten Dissecting
Probe (50 mm, 0.5 mm diameter rod) under a dissecting
microscope (Olympus, SZ61). The stria vascularis was placed in
a glass-bottom microwell dish (dish diameter: 35 mm; microwell
diameter: 14 mm; coverglass: 0.16–0.19 mm; MatTek Corp.)
filled with the physiological solution. A glass coverslip (0.16 mm)
was then positioned over the stria vascularis, and the tissue was
gently sandwiched between the glass surfaces. Gentle pressure was
applied to compress the stria vascularis against the two glass
surfaces. By repeating this step, the non-vascular tissues were
dispersed into the solution and separated from the capillaries.
Non-vascular cells were gently flushed away with 100 ml micro-
peptide, while the clean microvessels adhered and ‘‘printed’’ onto
the bottom of the dish, which is analogous to the offset-printing
deposit of a pattern of ink onto paper. The isolated capillaries were
then transferred to a microfuge tube. For mass spectrum analysis,
capillaries were collected from a total of 100 mice cochlear stria
vascularis. After the initial dissection, all the steps were performed
under a laminar-flow hood to reduce keratin contamination.
Protein identification by LC-MS/MS and data analysis
The tryptic peptides were analyzed by 2D-LC-MS/MS. In
brief, a 10062.1 mm strong cation-exchange (SCX) column
(Polysulfoethyl A, 5 mm particle size, 300 A ˚ pore diameter) was
prepared for ion-exchange chromatography as instructed by the
manufacturer (The Nest Group, Inc.). Tryptic peptides were
injected onto the SCX column at a 200 ml/min flow rate. The
operating conditions for the analytical column were mobile phase
A containing 10 mmol/L sodium phosphate (pH 3.0) and 25%
acetonitrile, along with mobile phase B containing 10 mmol/L
sodium phosphate (pH 3.0), 25% acetonitrile and 350 mmol/L
potassium chloride. Following 5 minutes of loading and washing in
mobile phase A, peptides were eluted using a linear gradient of 0%
to 50% B over 45 min, followed by a linear gradient of 50% to
100% B over 20 min. One-minute fractions were collected and
dried by vacuum centrifugation and then redissolved by shaking in
100 ml of 5% formic acid. Portions of each fraction (40 ml) were
analyzed by LC-MS/MS using an Agilent 1100 series capillary LC
system and an LTQ linear-ion trap mass spectrometer (Thermo
Inc.) using a standard electrospray source fitted with a 34-gauge
metal needle (Thermo Inc.). Chromatography was achieved using
an Eksigent nanoLC to generate a gradient using the following
chromatographic conditions: mobile phase A: water, acetonitrile,
formic acid, trifluoroacetic acid (95, 4.89, 0.1, 0.01, v/v/v/v);
mobile phase B: acetonitrile, isopropanol, water, formic acid,
trifluoroacetic acid (80, 10, 9.89, 0.1, 0.01, v/v/v/v/v). Mobile
phase B was ramped from 2% to 45% over 40 minutes, increased
to 80% in 5 minutes, and held for 5 minutes before being returned
to starting conditions. The flow was regulated at 200 nl/min and
directed through a 75 mm6150 mm column packed in house with
Astrosil (5 mm particle size, 100 A ˚ pore size, C18 reverse phase
chemistry; Stellar Phases) coupled to a 5 mm tapered emitter (New
Objectives). Prior to analytical chromatography, 5 ml of tryptic
digest was injected onto a 150 mm 620 mm sample trap packed
with Poros R10; the trap was washed with mobile phase A to
remove salts and contaminants and then was switched in line with
the analytical column. Tandem mass spectrometry data was
collected using a QSTAR XL hybrid time-of-flight mass
spectrometer (Applied Biosystems) under the following conditions:
spray voltage 1800 to 1900 V; TOF-MS scan m/z 400 to 1600,
0.5 sec; TOF-MS/MS scan m/z 50 to 2000, 2.0 sec, 9 sec
exclusion.
LC-MS/MS data were converted to DTA files using
extract_msn software (Thermo Inc.) with the following parame-
ters: MW range 550 to 4000, group scan 1, minimum group count
1, minimum ion count 25, and an absolute threshold of 500. The
175,961 DTA files were analyzed using SEQUEST (version27,
Thermo Inc.) and a suite of in-house software [15]. A mouse
species subset of the Swiss-Prot protein database (version57.2;
16,115 entries) was prepared with concatenated reversed entries
and searched with SEQUEST. A parent ion mass tolerance of 2.5
Da was used with average parent ion mass and average fragment
ion masses. Cys had a static modification mass of +57 Da
(alkylation with iodoacetimide). No enzyme specificity was used.
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peptide charge, and the number of tryptic termini was set to
allow 34,982 identifications, where 445 matches were to reversed
entries for an estimated peptide false discovery rate of 1.3%.
Protein identification lists were prepared using DTASelect
(Version 1.9, the Scripps Research Institute) with post processing
of results to improve spectral-count accuracy and allow more strict
protein identification criteria. Proteins were considered present in
a given sample, if they had two or more peptides with distinct
sequences, having a unique count greater than or equal to one in
the respective sample. The number of proteins (including
contaminants) was 652, with 9 matches to reversed entries for
an estimated protein false discovery rate of 1.3%. Each protein
identification was assigned a cellular function by PIPE (http://
pipe.systemsbiology.net/pipe/#Summary) based on Genome
Ontology (GO) terms.
Noise exposure
Animals were exposed to broadband noise at 120 dB SPL for
three hours for two consecutive days. This noise-exposure protocol
is routinely used in our laboratory and produces a permanent
cochlear-sensitivity loss [16].
Protein determination
In this study, total protein in each different experiment was
measured in a fluorescence microplate reader using with a
CBQCA protein quantitation kit (Cat# C-6667, Invitrogen).
Isolated stria vascularis capillaries from one mouse were mixed
with 140 ml 0.1 mol/L borate buffer (pH 9.3), sonicated for 2 min,
and incubated for 30 min on ice to allow protein extraction. After
a short centrifugation at 12,000 rpm, 135 ml of the capillary
extract was sampled for protein quantitation. The plates were
incubated for 1 h at room temperature, and the increase in
fluorescence was assayed at emission (535 nm) and at excitation
(485 nm) using a TECAN GENios Plus ELISA reader (TECAN)
and the XFluo 4 software (TECAN). Bovine serum albumin was
used as the quantitation standard. Control experiments were
carried out to ensure that the borate buffer did not interfere with
protein quantitation.
Immunofluorescence confocal microscopy
The tissue samples were fixed in 4% paraformaldehyde at 4uC
for 2 h, washed in PBS for 30 min, permeabilized in 0.5% Triton
X-100, then immunoblocked in a solution of 10% goat serum in
1% bovine albumin in PBS for 30 min. The specimens were
incubated with primary antibodies (see antibodies below) and
secondary antibodies (goat Alexa Fluo 488-conjugated anti-mouse
and anti-rabbit IgG antibodies, Invitrogen). The fluorescence was
visualized on an Olympus IX81 inverted microscope fitted with an
Olympus Fluoview FV1000 confocal laser microscope system. The
samples were examined as above, and Z-series stacks were
examined at an interval of 1 mm. The Z-series images were
projected using Image J 1.30 software (National Institutes of
Health) and processed by Adobe Photoshop (vCS3, Adobe
Systems).
Transmission electron microscopy and scanning electron
microscopy
For the transmission electron microscopy, cochlear lateral wall
tissue was dissected from the control and noise-exposed animals.
Segments of the cochlear lateral wall from the basal turns were
fixed overnight in phosphate-buffered 3% glutaraldehyde-1.5%
paraformaldehyde and post-fixed in 1% osmium. The tissues were
dehydrated, embedded in Araldite plastic, sectioned, stained with
lead citrate and uranyl acetate, and viewed in a Phillips, CM, 100
transmission electron microscope (Eindhoven, the Netherlands).
For the scanning electron microscopy, isolated capillary samples
were fixed and imaged by using an ESEM (FEI Quanta 200,
Hillsboro, OR) at a stage height of approximately 10 mm, 15 kV,
and magnification of 40006. The recorded images were saved in
TIFF format.
Immunoblots
The total lysate from the stria vascularis capillaries was obtained
by sonicating the tissue in RIPA lysis buffer (Cat# 87787, Thermo
Inc.) with a protease inhibitor mixture (Cat# P8340, Calbiochem).
After centrifugation, the supernatant was collected, and the
protein was quantified by the CBQCA assay described above.
Protein extracts were separated by SDS/PAGE and analyzed by
immunoblots with relevant antibodies. For densitometry, non-
saturated developed films were scanned using a Canon LiDE
scanner (Canon, USA), and mean pixel density of each band
wasmeasured using Image J 1.30 software (National Institutes of
Health). Measurements were standardized to actin loading
control, and fold changes vs. control was calculated.
Co-immunoprecipitation assay
Interaction between ATP1A1 and occludin or PKCg was
determined by coimmunoprecipitation. Equal amounts of protein
from the stria vascularis capillary lysates prepared with RIPA
buffer were incubated on a rotator overnight with an antibody
bound to protein A agarose beads (Cat# sc-2001, Santa Cruz
Biotechnology, Inc) at 4uC. The proteins bound to the beads were
separated by SDS-PAGE, and coimmunoprecipitating proteins
were analyzed by immunoblotting.
Protein-protein interaction assay
Purified recombinant ATP1A1 protein (250 ng) and purified
recombinant PKCg protein (250 ng) were incubated together in
250 ml PBS at 4uC for 2 h. Next, either anti- ATP1A1 antibody or
anti-PKCg antibody was incubated with the reactions for 4 h at
4uC. Where indicated, ouabain (10 mmol/L) was added followed
by additional 1 h incubation. Protein A/G agarose beads (Santa
Cruz Biotechnology, Inc.) were then added to the reactions and
incubated overnight at 4uC with rocking. The beads were washed
four times with PBS and boiled in a Laemmli sample buffer. The
samples were separated by SDS-PAGE, and the proteins were
detected by immunoblotting with indicated antibodies.
RT-PCR
Total RNA from the cochlear stria vascularis capillaries was
separately extracted, with RNeasy (QIAGEN), from the control
and NE groups. Each group was comprised of five mice for
analysis of mRNA levels of Na
+/K
+-ATPase a1 (ATP1A1), b1
(ATP1B1) and b2 (ATP1B2) with quantitative RT-PCR. Two mg
of total RNA and 100 ng of random hexamer were used to make
20 ml of cDNA by SuperScript II (Invitrogen) following the
manufacturer’s instructions. The cDNA synthesized from total
RNA was diluted 10-fold with DNase-free water. Transcript
quantities were assayed by corresponding TaqMan gene expres-
sion assay: ATP1A1 (Cat# Mm00523255_m1; Applied Biosys-
tems), ATPB1 (Cat# Mm00437612_m1) and ATP1B2 (Cat#
Mm00442612_m1) with a model 7300 real-time PCR system
(Applied Biosystems). Thermal cycle conditions were an initial
hold of 50uC for 2 m, 95uC for 10 m, then 40 cycles of 95uC for
15 s and 60uC for 1 m. The samples were run in triplicate for each
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guidelines provided by Applied Biosystems. The comparative
cycle threshold (CT) method (DDCT quantitation) was used to
calculate the difference between samples. Quantitative data
analysis was followed according to the suggestions of the
manufacturer.
Enzymatic activity assay
Both PKCg and Na
+/K
+-ATPase activity were respectively
determined withaPKCgKinEASE
TMFPFluoresceinGreenAssay
Kit (Millipore) and an ATPase assay kit (Novus Biologicals). For the
PKCg activity measurement, the stria vascularis capillary homog-
enates were mixed in the reaction buffer, which was composed of
KinEASE buffer and ATP. The PKCg activity was assayed using a
Fluoresence Polarization Reader (BioTek) with excitation at
458 nm and emission at 530 nm. For the Na
+./K
+-ATPase activity
measurement, the isolated stria vascularis capillary homogenates
were mixed in the reaction buffer which consisted of 50 mmol/L
Tris, 2.5 mmol/L MgCl2 and 0.5 mmol/L ATP. The total ATPase
activity was assayed in the reaction mixture. The resting ATPase
activity, except Na
+/K
+-ATPase, was assayed in the presence of an
additional 1 mmol/L ouabain in the reaction mixture. Na
+/K
+-
ATPase specific activity was calculated by subtracting the resting
ATPase activity from the total ATPase activity. The enzyme activity
was determined by the amount of inorganic phosphate (Pi) released
from the substrate ATP. The Pi concentrations were read using a
TECAN GENios ELISA reader (TECAN) at a wavelength of
595 nm. Enzyme specific activity equals concentration (mmol) of Pi
liberated per mg protein per hour.
Permeability analysis
Vascular permeability was assessed using the method based on
determining the limits of the stria vasculature capillaries and the
diffusion limits of the IgG extravasated around the vessel. As more
permeability on the BLB (more extravasations) generates a higher
gradient of IgG, and diffusion depends on the gradient, high levels
of IgG will extend longer from the vessel. Image treatment and
fluorescence analyses of the images were performed by means of the
Image J software (National Institutes of Health, USA). In order to
determine the limits of the capillaries the strategy consisted on the
following steps: First, on the image showing collagen-IV immuno-
staining, arbitrary lines were traced transversally crossing each
blood vessel. Second, the profile intensity of the staining along each
line was plotted. Third, a horizontal threshold line defining valid
datawasdrawn over eachprofile level in order to definethe limitsof
stain positiveness. Fourth, the diameter of each vessel (VD) was
determined after converting pixels to mm. In order to determine the
limits of IgG extravasation, the last three steps were applied on the
equivalent images corresponding to IgG staining, using the same
lines transversally crossing each blood vessel. The extension of the
extravasation (EE) was obtained by converting pixels of the
positively stained IgG region to micrometers (Figure S1).
Drug application
The PKCgPS peptide, Myr-TRKRQRAMRRRVHQING
[17], and a control peptide with scrambled sequence, (PKCgNC)
(Myr-RMINKARVRGRAQRHG-OH) [18], were custom synthe-
sized by GenScript. Both the peptides and ouabain solution were
prepared by being dissolved in a physiological solution. For in vivo
studies, sterile surgical procedures were used to apply 10 mlo fa
0.5 mmol/L PKCgPS solution to the round window (RW) for
30 m prior to applying 1 mmol/L ouabain (Cat# 4995, Calbio-
chem) to the RW or exposing animals to noise. The PKCgNC
solution treated ears served as a control. For in vitro studies, the
isolated stria vascularis capillaries were treated with 50 mmol/L of
PKCgPS solution for 30 m before treating with 100 mmol/L
ouabain for 5 hrs. The isolated capillaries treated with PKCgNC
solution served as control samples for the experiments.
Antibodies and purified proteins
The following antibodies were used in this study: mouse
monoclonal anti-actin (Cat# MAB1501, Chemicon), anti- Na
+/
K
+-ATPase a1(C at # 05-369, Millipore),anti-desmin(Cat# ab6322,
Abcam), anti-PKCg (Cat# 610814, BD Transduction); rabbit
polyclonal anti-Kir 4.1(Cat# AB5818, Chemicon), anti-occludin
(Cat# 40-4700, Invitrogen), anti-ZO-1 (Cat# 40-2300, Invitrogen),
anti-Collagen type IV (Cat# ab6586, Abcam), anti-NG2 (Cat#
NBP1-20170, Novus Biologicals), anti-PECAM-1(Cat# ab24590,
Abcam). The purified recombinant proteins used in this study were:
ATP1A1 (Cat# TP301009) from Origene Technologies, Inc. and
PKCg (Cat# 10-782-55103) from Geneway Biotech, Inc.
Statistics
Data are presented as mean 6 SEM of at least three independent
experimentswith threeormorereplicatesand analyzed bywilcoxon
signed-rank test, with P,0.05 considered significant.
Results
Isolation of stria vascularis capillaries
In this study, a unique sandwich-dissociation method was
developed to isolate stria vascularis capillaries from the mouse
cochlea. The procedure is illustrated in Figure 1 (for detailed
information see Materials and Methods). Preparation purity was
assessed by differential interference contrast (DIC), confocal
fluorescence microscopy and scanning electron microscopy
(SEM). Representative images are shown in Figure 2. Isolated
capillaries labeled for collagen type IV, a predominant component
of basement membrane, define the capillary structure, as shown in
Figure 2A. Additional immunolabeling with CD31, an endothelial
cell (EC) marker protein, and NG-2, a pericyte (PC) marker
protein, showed the cellular composition of the isolated capillaries
(Figure 2B). Hoechst staining detected cell nuclei only in vascular
cells, including PC and EC (Figure 2B), indicating the absence of
non-vascular cell contamination. SEM verified the lack of non-
vascular cells contamination (Figure 2C).
Immunoblot analysis for known protein markers of PCs and
intermediate cells (IC) further verified preparation purity. ICs,
non-vascular cells, are a likely contaminate as these cells form a
honeycomb network and surround capillaries with their dendritic
processes [19]. While Kir 4.1, an IC marker, was not detected in
the capillary fraction indicating the preparation was free of ICs,
desmin, a PC marker protein, was detected in the capillary
fraction (Figure 2D). Next, capillary protein extracts were
separated by SDS-PAGE, and a protein migrating with the same
molecular weight as ATP1A1 (112 kD) was predominant in the
purified capillaries (Figure 2E), consistent with the proteomic data
described below. Although minimal contamination cannot be
ruled out for individual preparations, we are confident our
isolation was sufficiently pure to achieve a high degree of blood-
labyrinth barrier protein enrichment.
Categorization of stria vascularis capillary proteins
identified ATP1A1 subunit as the most abundant protein
in the blood-labyrinth barrier
Capillaryprotein(19 mg)obtainedfrom100cochleaewasdigested
with trypsin and analyzed by 2D-LC/MS/MS. A total of 652
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than 1.5%. Details of the analysis and a list of identified proteins are
found in Dataset S1. The relative mass-abundance of proteins in
shotgunproteomicsamplesisproportionaltothenumberofassigned
MS/MS spectral counts [20]. While the accuracy of spectral
counting for estimation of relative protein abundance has not been
rigorously tested, the technique provides a useful ranking of protein
abundance in complex mixtures. The identified capillary proteins
were ordinally listed by assigned MS/MS spectra (Dataset S1).
The putative barrier proteome was further analyzed against
tabulated categories of a gene ontology database to obtain a
functional overview of the blood-labyrinth barrier proteins (Dataset
S2). Proteins were classified into categories based on ‘‘biological
process,’’ with the categories weighted by total spectral count
(Figure 3A). Abundance-weighting of annotations provides an
informative picture of tissue function. Annotation analysis was also
done for ‘‘cellular component’’ (Figure S2) and ‘‘molecular function’’
(Figure S3). As expected under ‘‘biological process,’’ the blood-
labyrinth barrier is rich in proteins for molecular transport (42% of
total spectral counts) and metabolic processes (19% of total spectral
counts) (Figure 3A). Metabolic enzymes are also highly expressed in
the blood-labyrinth barrier, including glutathione S-transferase
(GST), prosaposin, leukotriene A4 hydrolase, and glutamate
oxaloacetate transaminase. In particular, on a mass basis, ATP1A1
was the most abundant protein; peptides covering 45% of the amino
acid sequence of ATP1A1 were identified (Figure 3B). A represen-
tative tandem mass spectrum of a ATP1A1 peptide is shown
(Figure 3C). Expression of ATP1A1 in stria vascularis capillaries was
further validated by immunocytochemistry (Figure 3D).
ATP1A1 regulation of TJ permeability involves occludin
phosphorylation in the blood-labyrinth barrier
While ATP1A1 is known to regulate TJ permeability through
interactionwithTJproteinsinthe epithelialbarrier[21],thepresent
study addresses the question of whether ATP1A1 is necessary for TJ
function in the endothelial barrier. The link between ATP1A1 and
occludin was investigated by co-immunoprecipitation using capil-
lary protein lysate, with the finding that ATP1A1 is in a complex
with occludin (Figure 4A and 4B). By dual-labeling immunofluo-
rescence analysis, ATP1A1 was further identified to co-localize with
occludin in the blood-labyrinth barrier (Figure 4C).To determine
whether ATP1A1 regulates TJ permeability, ouabain, a specific
pharmacological inhibitor of Na
+/K
+-ATPase activity [22], was
applied to the round window membrane of the cochlea. Blood-
labyrinth barrier permeability was then assessed from the relative
extension of serum protein IgG extravasation (REE) outward from
the capillary wall. Under control conditions, IgG was restricted to
the lumen of capillaries (Figure 4D). In contrast, ouabain treatment
resulted in a statistically significant increase in blood-labyrinth
barrier permeability as demonstrated by leakage of IgG from the
capillary wall (Figure 4D and 4E, P,0.01).
To investigate whether the observed change in permeability was
associated with TJ reorganization, we examined the effect of
ouabain treatment on post-translational modification of a pivotal
components of endothelial TJs, occluding. Phosphorylation of
occludin is essential for TJ assembly and is a critical regulator of
barrier integrity [23,24,25]. Isolated stria vascularis capillaries were
treated with ouabain and the phosphorylation state of occludin was
examined by immunoblot analysis. In the untreated control,
occludin migrated as two major bands which included a slower
migrating ,70 kD hyperphosphorylated form (a) and a faster
migrating ,65 kD dephosphorylated form (b) (Figure 4F). Follow-
ing inhibition of Na
+/K
+-ATPase, the a/b ratio was significantly
increased, indicating phosphorylation of occludin (Figure 4G). This
result suggests that normal Na
+/K
+-ATPase activity is required for
maintaining the phosphorylation state of occludin.
Decreased Na
+/K
+-ATPase activity increases TJ
permeability via PKCg phosphorylated occludin
The phosphorylation status of TJ proteins is mediated by several
different protein kinases [26] and phosphatases [27]. Of interest,
PKCg regulation of epithelial TJ permeability is affected through
Figure 1. Isolation of capillaries from the stria vascularis of adult mouse cochlea. Flow diagram of the steps involved in capillary isolation
from the stria vascularis and downstream processing for immunohistochemistry, immunoblot, and 2D-LC MS/MS analysis.
doi:10.1371/journal.pone.0016547.g001
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induced hyper-phosphorylation of occludin in endothelial TJs
could be mediated by PKCg, co-immunoprecipitation using
capillary protein lysate was performed. The results provide clear
evidence that PKCg and ATP1A1 are in a complex in vivo
(Figure 5A and 5B). A direct interaction between ATP1A1 and
PKCg was shown by an in vitro binding assay using purified
proteins (Figure 5C). The addition of ouabain (10 mM) to
preformed ATP1A1-PKCg complexes did not disrupt the
interaction. Next, the functional interaction between ATP1A1
and PKCg was tested. Using a fluorescein assay, total PKCg
activity was measured as 4.37 6 0.43 units/mg protein in control
isolated stria vascularis capillaries, which increased significantly to
7.01 6 0.28 units/mg protein when the capillaries were treated
with ouabain for 3 h (Figure 5D). These results suggest that the
physical interaction between PKCg and ATP1A1 has functional
relevance in regulation of TJ permeability.
To explore this possibility, the interaction between PKCg and
occludin phosphorylation was examined. Prior to ouabain treat-
ment, tissues were pretreated with a PKCg pseudo substrate
(PKCgPS) which mimics the substrate of PKCg and competitively
inhibits PKCg kinaseactivity [17]. Inhibition of PKCg significantly
attenuated ouabain-induced hyperphosphorylation of occludin
(Figure 5E and 5F). Reduction of occludin phosphorylation by
PKCg activity inhibition resulted in decreased TJ permeability
following inhibition of Na
+/K
+-ATPase by ouabain (Figure 5G). In
contrast, no change was detected in occludin phosphorylation or TJ
permeability in tissues pretreated with the control peptide,
PKCgNC (Figure 5E–G). The results provide evidence that
decreased Na
+/K
+-ATPase activity increases endothelial TJ
permeability via PKCg phosphorylation of occludin.
ATP1A1 is implicated in noise-induced disruption of the
blood-labyrinth barrier
NoisetraumaresultsindepletionofintracellularATPaswellasin
changes in vascular permeability [28]. The link between ATP
depletion and permeability changes is the decreased Na
+/K
+-
ATPase activity that ATP depletion engenders [29]. To assess
Figure 2. Characterization of isolated SV capillaries. A, A DIC image (Left) of an isolated mouse SV capillary network obtained by the
‘‘sandwich-dissociation’’ method (see Materials and Methods). The capillary is immunolabeled with an antibody for collagen type IV to show the
basement membrane (Right). B, Images of isolated capillaries triple labeled for EC marker protein CD31 (red channel), PC marker protein NG-2 (green
channel), and Hoechst for nuclei (blue channel) verify absence of non-vascular cell contamination in the capillary preparation. C, A scanning electron
micrograph of isolated capillaries (Left), with the accompanying higher magnification image, shows PCs on the isolated capillaries (Right, arrows). D,
Immunoblot analysis of the isolated capillaries. The pericyte marker protein desmin is detected only in the capillary fraction, while the intermediate
cell marker protein Kir 4.1 is only detected in the non-vascular fraction, confirming the preparation is uncontaminated by intermediate cells. SVC, stria
vascularis capillary fraction; SVN, stria vascularis non-vascular fraction. E, One-dimensional SDS-PAGE separation of the isolated capillary proteins,
silver stained. Migration positions corresponding to the NKA a1 subunit (112 kD) and its major bands are indicated (Scale bars: A and B, 100 mm; C,
50 mm) Data in all panels are representative of at least 3 separate experiments.
doi:10.1371/journal.pone.0016547.g002
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PLoS ONE | www.plosone.org 6 January 2011 | Volume 6 | Issue 1 | e16547Figure 3. Classification of isolated stria vascularis capillary proteins identified ATP1A1 as the most abundant protein in the blood-
labyrinth barrier. A, Spectral count-weighted tabulation of GO annotation by biological process. Proteins involved in transport (42%) and
metabolism (19%) are highly expressed in the blood-labyrinth barrier. B, The sequence of ATP1A1 covered by identified peptides is outlined in yellow
(45% coverage). The alkylated residues (green) were identified by iodoacetamide treatment. C, A representative MS/MS spectrum for peptide 630–
645 of ATP1A1. Graphically displayed are the fragment ions identified by SEQUEST from the tandem mass spectrometry data. Mass-to-charge (m/z)
values are indicated next to each peak, along with positions of y-ions (blue) and b-ions (red). Unmatched ions are displayed as black. D, Localization
of ATP1A1 (green) in stria vascularis capillaries (red, antibody for collagen type IV). A merged image (Right) shows the distribution of ATP1A1 along
the capillary. Data in all panels are representative of at least 3 separate experiments. (Scale bars: D,2 0mm).
doi:10.1371/journal.pone.0016547.g003
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+/K
+-ATPase activity, and corollary TJ
reorganization, can account for noise-induced vascular leakage,
animals were exposed to wide-band noise at 120 dB SPL for 3 h a
day for 2 consecutive days. Hearing thresholds at all test frequencies
were elevated as assessed by auditory brain-stem response (ABR)
(Figure S4). Immediately after noise exposure, blood-labyrinth
barrier permeability was visualized with an REE of the serum
protein IgG. Confocal imaging showed widespread blood-labyrinth
Figure 4. ATP1A1 regulation of TJ permeability involves occludin phosphorylation in the blood-labyrinth barrier. A and B, Co-
immunoprecipitation using isolated stria vascularis capillary lysates demonstrates that ATP1A1 is in a complex with occludin. Preimmune goat IgG
served as a negative control. C, Immunolabeling of stria vascularis capillaries for occludin (Left, red) and ATP1A1 (Middle, green). The merged image
(Right) shows that occludin and ATP1A1 co-localization. D, Confocal images show increased TJ permeability in ouabain-treated tissues (Lower)
compared to control tissues (Upper). Serum protein IgG (green, antibody for IgG (H+L) is outside the lumen of the capillary (red, antibody for collagen
type IV). E, REE analysis confirmed the significantly increased permeability of ouabain-treated tissues (**P=0.005,0.01). F, Immunoblot analysis
shows occludin migrates as two bands, hyperphosphorylated a (,70 kD) and dephosphorylated b (,65 kD), in both control and ouabain-treated
tissues. G, The ratio of a band to b band in ouabain-treated tissues was significantly increased (**P=0.007,0.01). Values in E and G are mean 6 SEM
(n=10). (Scale bars: D,2 0mm). REE: relative extension of serum protein IgG extravasation; DV: diameter of the vessels; EE: extension of IgG
extravasation.
doi:10.1371/journal.pone.0016547.g004
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capillary wall in noise-exposed (NE) animals (Figure 6A). Quanti-
fication analysis revealed a significant increase in blood-labyrinth
barrier permeability in the NE animals compared to unexposed
control animals (Figure 6B, P,0.01). Further, transmission electron
microscope (TEM) imaging displayed a reduced number of TJ
contact points in the NE animals in comparison to the control mice
(Figure 6C), indicating that loud sound-induced permeability
changes are associated with altered TJ organization. Next, Na
+/
K
+-ATPase specific activity was examined by microcolorimetric
assay in isolated stria vascularis capillaries of the control and NE
animals, and a remarkable decrease in Na
+/K
+-ATPase activity in
the NE animals was observed (Figure 6D, P,0.01). Interestingly,
expression of ATP1A1 was significantly increased at both the
mRNA and protein levels following noise exposure (Figure S5).
Next, investigation was done to determine if post-translational
modifications of TJ proteins occurrs upon noise exposure by
immunoblot analysis (Figure 6E). The a/b ratio of occludin was
significantly increased in the NE animals in comparison to the
control mice (Figure 6F, 3.9 fold, P,0.01). The shift to the slower
migrating form of occludin can be attributed to a change in
phosphorylation status in response to noise exposure. To
determine whether noise-exposure leads to PKCg phosphoryla-
tion of occludin, PKCgPS was applied to the round window
membrane of the cochlea before noise exposure. Inhibition of
PKCg activity significantly attenuated both occludin hyperpho-
sphorylation (Figure 6G and 6H), and increased TJ permeability
was observed in the untreated NE animals (Figure 6I). No
attenuation was found in animals pretreated with the control
peptide PKCgNC (Figure 6G–I). The correlation between blood-
labyrinth barrier disruptions and the phosphorylation state of
endothelial occludin strongly suggests that noise-induced blood-
labyrinth barrier leakage is regulated by PKCg activity.
Discussion
Proteomic screening of the blood-labyrinth barrier using a
‘‘sandwich-dissociation’’ method, in combination with shotgun
Figure 5. Decreased Na
+/K
+-ATPase activity increases TJ permeability via PKCg phosphorylated occludin. A and B, Co-
immunoprecipitation using isolated stria vascularis capillary lysates shows that PKCg is in a complex with ATP1A1. Goat IgG served as a negative
control. C, Protein-protein interaction analysis with purified ATP1A1 (250 ng) and PKCg (250 ng). Ouabain (10 mM) was added where indicated.
Control lanes consisted of either anti-ATP1A1 antibody and purified PKCg or anti-PKCg antibody and purified ATP1A1. D, Ouabain inhibition of Na
+/
K
+-ATPase activity causes increased PKCg activity in isolated stria vascularis capillaries (*P=0.013,0.05). E and F, PKCgPS pretreatment significantly
attenuated ouabain-induced occludin hyperphosphorylation compared to pretreatment with PKCgNC (* P=0.011,0.05). G, REE analysis shows a
significant attenuation in ouabain-induced permeability in PKCgPS pre-treated tissues (**P=0.005,0.01). REE, relative extension of serum protein
IgG extravasation; DV, diameter of the vessels; EE, extension of IgG extravasation. Values in D, F and G are mean 6 SEM (n=10).
doi:10.1371/journal.pone.0016547.g005
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+/K
+-ATPase activity is a mechanism for noise-induced blood-labyrinth
barrier disruption. A, Confocal images of IgG leakage from capillaries in disrupted blood-labyrinth barrier of noise-exposed (NE) animals. Stria
vascularis capillary networks were labeled with anti-collagen type IV (red) and anti-serum protein IgG (H+L, green) antibodies. IgG was confined in
normal stria vascularis capillaries (Left) but not in NE animals (Right). B, REE analysis shows significantly increased blood-labyrinth barrier permeability
in NE mice (**P=0.005,0.01). REE: relative extension of serum protein IgG extravasation; DV: diameter of the vessels; EE: extension of IgG
extravasation. C, Transmission electron microscope images show alterations in TJ ultrastructure from NE. TJ contact points were reduced in response
to NE (Right, Inset). In contrast, TJ contact points were extensive in control mice (Left, Inset). Insets display higher magnification of TJ between ECs. D,
NE caused decreased Na
+/K
+-ATPase activity in stria vascularis capillaries in NE animals (** P=0.005,0.01). E, Immunoblots for occludin from isolated
stria vascularis capillaries of control and NE mice. Two bands, hyperphosphorylated a (,70 kD) and dephosphorylated b (,65 kD), were detected. F,
Densitometry of the immunoblot results found a 3.9-fold increase in the (a/b) ratio following NE (**P=0.005,0.01). G, Immunoblots for occludin
from NE mice pre-treated with PKCgNC and PKCgPS. H, A 2.4-fold decrease in the (a/b) ratio occurred with PKCgPS pre-treatment (*P=0.022,0.05).
I, REE analysis confirms decreased permeability in NE mice pre-treated with PKCgPS (*P=0.021,0.05). Values in B, D, F, H, and I are mean 6 SEM
(n=10). BM: basal membrane; EC: endothelial cell; IC: intermediate cell; RBC: red blood cell; TJ: tight junction. (Scale bars: A, 20 mm; C, 500 nm).
doi:10.1371/journal.pone.0016547.g006
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ATP1A1, a key component of tight junctions in polarized
epithelial cells [30], was identified as the most abundant protein
in the barrier. We show here that ATP1A1 regulates TJ
permeability in the blood-labyrinth barrier through a mechanism
involving occludin phosphorylation.
The blood-labyrinth barrier in the stria vascularis, comprised of a
dense capillary network of endothelial cells, surrounding pericytes, and
basement membrane [19],is anatomically different from blood barriers
in brain and retina. In contrast to the high degree of vascularization
and loose association with surrounding nonvascular tissue present in
other barriers, the blood-labyrinth barrier is a sandwich of epithelial
marginal cells and mesodermal basal cells interconnected by TJs.
Dendrite-like projections of intermediate cells, dispersed between the
two cell layers, make close contacts with capillaries through gap
junctions. The complexity of the capillary beds has made isolation of
stria vascularis cells from surrounding non-vascular cells technically
challenging. The ‘‘sandwich-dissociation’’ method, reported here,
cleanly separates intact stria vascularis capillaries from nonvascular
cells (Fig. 2), and enables functional proteomic study of the blood-
labyrinth barrier without significant contamination.
The mass spectrometry data was searched against a mouse
species subset of the current Swiss-Prot protein database, a
comprehensive database of 16,115 entries (Dataset S1). We note,
however, the list is not complete. Some TJ proteins are scarce or
have a limited number of trypsin cleavage sites, with the effect of
underrepresentation. Also, while vascular perfusion removes
contaminatingcells, blood proteins, such as albumin, are commonly
found in proteomic screens of endothelial cells [31]. Despite these
caveats, validation experiments indicate most of the proteins in
Dataset S1 are authentic blood-labyrinth barrier proteins.
While ATP1A1 is expressed at lower levels in non-vascular
tissue [32], our finding of ATP1A1 the most abundant protein in
the blood-labyrinth barrier is in concurrence with other studies
showing high expression of the subunit in blood-brain barrier [33].
ATP1A1 is a component of the Na
+/K
+-ATPase ion transporter.
Na
+/K
+-ATPase is a ubiquitously expressed oligomeric protein
composed of two essential polypeptide subunits, the catalytic a-
subunit (,112 kDa) and the b-subunit (,55 kDa) [34,35]. There
are four distinct a-subunit isoforms in mammalian cells (a1, a2, a3
and a4). All a-subunit isoforms have 10 transmembrane segments
with 5 extracellular loops, intracellular termini, and binding sites
for Na
+,K
+, ATP, and cardiotonic steroids, such as the specific
inhibitor ouabain [36]. Each, however, also has unique kinetic
properties and a distinctive response to second messenger signaling
[37]. ATP1A1 is considered to be a regulatory molecule, as it plays
a central role, not only in cellular ion homeostasis, but also in
regulation of permeability, modifying TJ proteins in epithelial
barriers of cell lines [30,38]. In contrast, the Na
+/K
+-ATPase b-
subunit is associated with the transmembrane helices and may
have a role in cell-to-cell adhesion [11].
The phosphorylation state of TJ proteins has a direct bearing on
barrier integrity [25]. Treatment with ouabain, a specific inhibitor
of Na
+/K
+-ATPase [39], increases blood-labyrinth barrier per-
meability by increasing phosphorylation of occludin (Figure 4D–
G). A number of regulators of protein phosphorylation, including
protein kinase C [26], tyrosine kinase c-Yes [40], and protein
phosphatase PP2A [22], have been reported to be involved in this
process.
This study is the first to have shown ATP1A1 is in a protein
complex with occludin and PKCg in the endothelial blood-
labyrinth barrier (Figure 4A and 4B and Figure 5A and 5B).
PKCg is demonstrated to regulate occludin phosphorylation and
TJ permeability in epithelia [18], and blockage of PKCg
attenuates occludin hyperphosphorylation. The current study,
however, provides direct evidence of a functional interaction
between ATP1A1 and PKCg. ATP1A1 inhibition upregulates
PKCg kinase activity, and subsequent hyperphosphorylation of
occludin reduces TJ contact points and increases permeability of
the barrier. The mechanism by which ATP1A1 inhibition
upregulates PKCg kinase activity was examined by in vitro binding
analysis, which further confirmed direct interaction between
ATP1A1 and PKCg. Moreover, this complex was not disrupted
by addition of ouabain to the preformed complexes (Figure 5C).
The ouabain-induced conformational change in ATP1A1 likely
activates PKCg kinase activity. This finding is analogous to the
Na
+/K
+-ATPase-Src complex in which ouabain binding by
ATP1A1 results in release and activation of the Src kinase domain
without disrupting the complex [41].
Acoustic trauma from loud sound causes both mechanical and
metabolic damage to cochlear cells [42,43]. Direct mechanical
damage to hair cells is the primary cause of noise-induced hearing
loss [44,45,46], while disruption of the cochlear blood flow and
blood-labyrinth barrier (CBLB) in the stria vascularis further
accelerates damage to hair cells by creating an ischemic and
hypoxic environment [16,47,48]. In particular, noise causes
cochlear hypoxia by generating edema in the stria vascularis with
breach of the blood-labyrinth barrier [49], while the molecular
mechanism for noise induced disruption of the barrier is not fully
understood. Mechanical damage and the harmful effects of
cytokine mediators, including vascular endothelial growth factor
and free radicals [50,51,52,53], have been implicated in the
increased vascular permeability with noise exposure [16].
The present study demonstrated for the first time the molecular
effect of noise exposure. It showed Na
+/K
+-ATPase activity is
reduced with noise exposure, leading to PKCg activation and
occludin hyperphosphorylation, resulting in vascular leakage and
disruption of the blood-labyrinth barrier (Figure 6). Transmission
electron microscopy provided corroborating evidence of signifi-
cantly reduced TJ ‘‘contact points’’ in noise-exposed animals. The
mechanism by which noise exposure decreases Na
+/K
+-ATPase
activity is thought to be through depletion of regional ATP or
through direct affects on the structure of the enzyme [54].
Impaired energy metabolism, accompanied by rapid depletion of
intracellular ATP, has been reported in noise-exposed animals
[28]. As ATP is the prime substrate of the Na+/K+ pump,
reduced ATP levels may have the effect of depressing Na
+/K
+-
ATPase activity, leading to PKCg activation and occludin
hyperphosphorylation. Na
+ would accumulate under conditions
of attenuated Na
+/K
+-ATPase activity. Interestingly, accumula-
tion of intracellular Na
+ upregulates genetic expression of
ATP1A1. Similarly, upregulated ATP1A1 expression is reported
in ouabain-treated rat kidney epithelial cells [55], offseting the
enzyme inhibition. We observed significantly increased expression
of ATP1A1 (but not the b subunit) at both the transcriptional and
translational levels in the strial blood-labyrinth barrier after noise
exposure (Figure S5).
In summary, the present study has established the use of
proteomic techniques on isolated stria vascularis capillaries. For
the first time, global proteomic analysis of the blood-labyrinth
barrier revealed a protein component in the barrier. Furthermore,
we found that ATP1A1 interaction with PKCg and occludin was
involved in the integrity of the blood-labyrinth barrier.
Supporting Information
Figure S1 Image analysis strategy designed to quantify
the diameter of stria vascualris microvessels and the
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anti-collagen IV antibody with an arbitrary (a, b) line traced. B,A
horizontal threshold is traced, and the vessel diameter (DV) is
obtained. C, The same vessel stained with anti-IgG antibody and
with the same arbitrary line (a, b) traced. D, The extension of IgG
extravasation (EE) has been determined after drawing the
background horizontal line. REE is defined as EE subtracted
from DV (REE = EE-DV). REE: relative extension of serum
protein IgG extravasation; DV: diameter of the vessels; EE:
extension of IgG extravasation.
(TIF)
Figure S2 Isolated capillary protein classification ac-
cording to cellular component. A, GO annotation by cellular
component. 544 proteins were identified to be associated with a
diverse cellular component and mitochondrial proteins, including
matrix proteins (17%), inner membrane proteins (16%) and outer
membrane proteins (1%), were highly expressed in the blood-
labyrinth barrier. B, Allocation of isolated stria vascularis capillary
proteins by cellular component showed the greatest number of
these proteins (95) were allocated to a mitochondrial matrix.
(TIF)
Figure S3 Isolated capillary protein classification ac-
cording to molecular function. A, GO annotation by
molecular function. 526 proteins were identified to be related to
molecular functions and proteins involved in catalytic activity
(31%) were highly expressed in the blood-labyrinth barrier. B,
Allocation of isolated stria vascularis capillary proteins by
molecular function showed that the greatest number of these
proteins (164) was allocated to catalytic activity and the smallest (1)
to electron carrier activity.
(TIF)
Figure S4 ABR hearing thresholds were measured from
the noise-exposed and control mice (n = 10) at 4, 8, 12,
16, 24 and 32 kHz. *Significantly different from control mice
(***P , 0.001). Error bars represent SEM.
(TIF)
Figure S5 The expression of ATP1A1 in response to
noise exposure. A, Real-time PCR showed the expression of
mRNAs of Na
+, ATP1A1, ATP1B1 and ATP1B2 in the control
and noise-exposed (NE) animals. ATP1A1 mRNA was highly
up-regulated in response to noise exposure. (** P = 0.0043, 0.01,
n = 3). However, ATP1B1 and ATP1B2 mRNA did not reveal a
significant difference in NE animals. B and C, Immunoblots
quantified by densitometry shows that expression of ATP1A1
was significantly increased in the NE animals. (* P = 0.032 ,
0.05, n = 5).
(TIF)
Dataset S1 Summary of the 652 proteins identified in
stria vascularis capillaries. Common contaminant, se-
quence-reversed decoys, and proteins with insufficient unique
peptide evidence are not listed.
(XLS)
Dataset S2 Functional classification and annotation of
proteins identified in this stria vascularis capillaries
proteomic study.
(XLS)
Author Contributions
Conceived and designed the experiments: YY XS. Performed the
experiments: XS YY MD TW IO LD. Analyzed the data: XS YY TW
JK PW LD. Contributed reagents/materials/analysis tools: XS. Wrote the
paper: XS YY TW AN PG.
References
1. Juhn SK, Hunter BA, Odland RM (2001) Blood-labyrinth barrier and fluid
dynamics of the inner ear. Int Tinnitus J 7: 72–83.
2. Juhn SK, Rybak LP (1981) Labyrinthine barriers and cochlear homeostasis.
Acta Otolaryngol 91: 529–534.
3. Lin DW, Trune DR (1997) Breakdown of stria vascularis blood-labyrinth barrier in
C3H/lpr autoimmune disease mice. Otolaryngol Head Neck Surg 117: 530–534.
4. Doi K, Mori N, Matsunaga T (1992) Adenylate cyclase modulation of ion
permeability in the guinea pig cochlea: a possible mechanism for the formation
of endolymphatic hydrops. Acta Otolaryngol 112: 667–673.
5. Klein M, Koedel U, Kastenbauer S, Pfister HW (2008) Nitrogen and oxygen
molecules in meningitis-associated labyrinthitis and hearing impairment.
Infection 36: 2–14.
6. Cohen-Salmon M, Regnault B, Cayet N, Caille D, Demuth K, et al. (2007)
Connexin30 deficiency causes instrastrial fluid-blood barrier disruption within
the cochlear stria vascularis. Proc Natl Acad Sci U S A 104: 6229–6234.
7. Suzuki M, Yamasoba T, Ishibashi T, Miller JM, Kaga K (2002) Effect of noise
exposure on blood-labyrinth barrier in guinea pigs. Hear Res 164: 12–18.
8. Calabria AR, Shusta EV (2006) Blood-brain barrier genomics and proteomics:
elucidating phenotype, identifying disease targets and enabling brain drug
delivery. Drug Discov Today 11: 792–799.
9. Pottiez G, Flahaut C, Cecchelli R, Karamanos Y (2009) Understanding the
blood-brain barrier using gene and protein expression profiling technologies.
Brain Res Rev 62: 83–98.
10. Motoyama A, Yates JR, 3rd (2008) Multidimensional LC separations in shotgun
proteomics. Anal Chem 80: 7187–7193.
11. Geering K (2008) Functional roles of Na,K-ATPase subunits. Curr Opin
Nephrol Hypertens 17: 526–532.
12. Skou JC, Esmann M (1992) The Na,K-ATPase. J Bioenerg Biomembr 24:
249–261.
13. Skou JC (2004) The Identification of the Sodium Pump. Biosci Rep 24:
436–451.
14. Violette MI, Madan P, Watson AJ (2006) Na+/K+ -ATPase regulates tight
junction formation and function during mouse preimplantation development.
Dev Biol 289: 406–419.
15. Wilmarth PA, Riviere MA, David LL (2009) Techniques for accurate protein
identification in shotgun proteomic studies of human, mouse, bovine, and
chicken lenses. J Ocul Biol Dis Infor 2: 223–234.
16. Shi X (2009) Cochlear pericyte responses to acoustic trauma and the
involvement of hypoxia-inducible factor-1alpha and vascular endothelial growth
factor. Am J Pathol 174: 1692–1704.
17. Osada S, Mizuno K, Saido TC, Akita Y, Suzuki K, et al. (1990) A phorbol ester
receptor/protein kinase, nPKC eta, a new member of the protein kinase C
family predominantly expressed in lung and skin. J Biol Chem 265:
22434–22440.
18. Suzuki T, Elias BC, Seth A, Shen L, Turner JR, et al. (2009) PKC eta regulates
occludin phosphorylation and epithelial tight junction integrity. Proc Natl Acad
Sci U S A 106: 61–66.
19. Takeuchi S, Ando M, Sato T, Kakigi A (2001) Three-dimensional and
ultrastructural relationships between intermediate cells and capillaries in the
gerbil stria vascularis. Hear Res 155: 103–112.
20. Liu H, Sadygov RG, Yates JR, 3rd (2004) A model for random sampling and
estimation of relative protein abundance in shotgun proteomics. Anal Chem 76:
4193–4201.
21. Rajasekaran AK, Gopal J, Rajasekaran SA (2003) Na,K-ATPase in the
regulation of epithelial cell structure. Ann N Y Acad Sci 986: 649–651.
22. Rajasekaran SA, Barwe SP, Gopal J, Ryazantsev S, Schneeberger EE, et al.
(2007) Na-K-ATPase regulates tight junction permeability through occludin
phosphorylation in pancreatic epithelial cells. Am J Physiol Gastrointest Liver
Physiol 292: G124–133.
23. Musch MW, Walsh-Reitz MM, Chang EB (2006) Roles of ZO-1, occludin, and
actin in oxidant-induced barrier disruption. Am J Physiol Gastrointest Liver
Physiol 290: G222–231.
24. Huber JD, Egleton RD, Davis TP (2001) Molecular physiology and
pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci
24: 719–725.
25. Harhaj NS, Antonetti DA (2004) Regulation of tight junctions and loss of barrier
function in pathophysiology. Int J Biochem Cell Biol 36: 1206–1237.
26. Stuart RO, Nigam SK (1995) Regulated assembly of tight junctions by protein
kinase C. Proc Natl Acad Sci U S A 92: 6072–6076.
27. Seth A, Sheth P, Elias BC, Rao R (2007) Protein phosphatases 2A and 1 interact
with occludin and negatively regulate the assembly of tight junctions in the
CACO-2 cell monolayer. J Biol Chem 282: 11487–11498.
28. Munoz DJ, Kendrick IS, Rassam M, Thorne PR (2001) Vesicular storage of
adenosine triphosphate in the guinea-pig cochlear lateral wall and concentra-
Na
+/K
+-ATPase a1 in the Endothelial-Blood Barrier
PLoS ONE | www.plosone.org 12 January 2011 | Volume 6 | Issue 1 | e16547tions of ATP in the endolymph during sound exposure and hypoxia. Acta
Otolaryngol 121: 10–15.
29. Gratton MA, Smyth BJ, Schulte BA, Vincent DA, Jr. (1995) Na,K-ATPase
activity decreases in the cochlear lateral wall of quiet-aged gerbils. Hear Res 83:
43–50.
30. Rajasekaran SA, Palmer LG, Moon SY, Peralta Soler A, Apodaca GL, et al.
(2001) Na,K-ATPase activity is required for formation of tight junctions,
desmosomes, and induction of polarity in epithelial cells. Mol Biol Cell 12:
3717–3732.
31. Durr E, Yu J, Krasinska KM, Carver LA, Yates JR, et al. (2004) Direct
proteomic mapping of the lung microvascular endothelial cell surface in vivo and
in cell culture. Nat Biotechnol 22: 985–992.
32. Stockwin LH, Blonder J, Bumke MA, Lucas DA, Chan KC, et al. (2006)
Proteomic analysis of plasma membrane from hypoxia-adapted malignant
melanoma. J Proteome Res 5: 2996–3007.
33. Eisenberg HM, Suddith RL (1979) Cerebral vessels have the capacity to
transport sodium and potassium. Science 206: 1083–1085.
34. Shull GE, Schwartz A, Lingrel JB (1985) Amino-acid sequence of the catalytic
subunit of the (Na++K+)ATPase deduced from a complementary DNA. Nature
316: 691–695.
35. Shull GE, Lane LK, Lingrel JB (1986) Amino-acid sequence of the beta-subunit
of the (Na++K+)ATPase deduced from a cDNA. Nature 321: 429–431.
36. Morth JP, Pedersen BP, Toustrup-Jensen MS, Sorensen TL, Petersen J, et al.
(2007) Crystal structure of the sodium-potassium pump. Nature 450: 1043–1049.
37. Xie Z (2003) Molecular mechanisms of Na/K-ATPase-mediated signal
transduction. Ann N Y Acad Sci 986: 497–503.
38. Betz WJ, Caldwell JH, Ribchester RR, Robinson KR, Stump RF (1980)
Endogenous electric field around muscle fibres depends on the Na+-K+ pump.
Nature 287: 235–237.
39. Cornelius F, Mahmmoud YA (2009) Interaction between cardiotonic steroids
and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme
conformation. Biochemistry 48: 10056–10065.
40. Chen YH, Lu Q, Goodenough DA, Jeansonne B (2002) Nonreceptor tyrosine
kinase c-Yes interacts with occludin during tight junction formation in canine
kidney epithelial cells. Mol Biol Cell 13: 1227–1237.
41. Tian J, Cai T, Yuan Z, Wang H, Liu L, et al. (2006) Binding of Src to Na+/K+-
ATPase forms a functional signaling complex. Mol Biol Cell 17: 317–326.
42. Hirose K, Liberman MC (2003) Lateral wall histopathology and endocochlear
potential in the noise-damaged mouse cochlea. J Assoc Res Otolaryngol 4:
339–352.
43. Ohlemiller KK (2008) Recent findings and emerging questions in cochlear noise
injury. Hear Res 245: 5–17.
44. Clifford RE, Rogers RA (2009) Impulse noise: theoretical solutions to the
quandary of cochlear protection. Ann Otol Rhinol Laryngol 118: 417–427.
45. Liberman MC, Kiang NY (1978) Acoustic trauma in cats. Cochlear pathology
and auditory-nerve activity. Acta Otolaryngol Suppl 358: 1–63.
46. Gratton MA, Schulte BA (1995) Alterations in microvasculature are associated
with atrophy of the stria vascularis in quiet-aged gerbils. Hear Res 82: 44–52.
47. Lamm K, Arnold W (1996) Noise-induced cochlear hypoxia is intensity
dependent, correlates with hearing loss and precedes reduction of cochlear blood
flow. Audiol Neurootol 1: 148–160.
48. Nuttall AL (1999) Sound-Induced Cochlear Ischemia/Hypoxia as a Mechanism
of Hearing Loss. Noise Health 2: 17–32.
49. Santi PA, Duvall AJ, 3rd (1978) Stria vascularis pathology and recovery
following noise exposure. Otolaryngology 86: ORL354–361.
50. Minami SB, Yamashita D, Ogawa K, Schacht J, Miller JM (2007) Creatine and
tempol attenuate noise-induced hearing loss. Brain Res 1148: 83–89.
51. Le Prell CG, Hughes LF, Miller JM (2007) Free radical scavengers vitamins A,
C, and E plus magnesium reduce noise trauma. Free Radic Biol Med 42:
1454–1463.
52. Fechter LD, Gearhart C, Fulton S, Campbell J, Fisher J, et al. (2007) JP-8 jet fuel
can promote auditory impairment resulting from subsequent noise exposure in
rats. Toxicol Sci 98: 510–525.
53. McFadden SL, Ohlemiller KK, Ding D, Shero M, Salvi RJ (2001) The influence
of superoxide dismutase and glutathione peroxidase deficiencies on noise-
induced hearing loss in mice. Noise Health 3: 49–64.
54. Hsu CJ, Shau WY, Chen YS, Liu TC, Lin-Shiau SY (2000) Activities of
Na(+),K(+)-ATPase and Ca(2+)-ATPase in cochlear lateral wall after acoustic
trauma. Hear Res 142: 203–211.
55. Muto S, Nemoto J, Okada K, Miyata Y, Kawakami K, et al. (2000) Intracellular
Na+ directly modulates Na+,K+-ATPase gene expression in normal rat kidney
epithelial cells. Kidney Int 57: 1617–1635.
Na
+/K
+-ATPase a1 in the Endothelial-Blood Barrier
PLoS ONE | www.plosone.org 13 January 2011 | Volume 6 | Issue 1 | e16547